The Valence Group has advised IGM on the sale of the company to NY-based private equity firm, Arsenal Capital, that specialises in making investments in middle market specialty industrial, healthcare and financial services companies. The terms of the transaction were not disclosed.
IGM is privately held and produces specialty chemicals for the global UV inks and coatings industry. Its products include monomers, oligomers, photoinitiators, additives and customized specialty compounds. The company was founded in 1999 and is based in Waalwijk, Netherlands, with offices and production facilities in Europe, US, South America and China. In 2012, the company is expected to generate sales of approximately €100 million.